Amedeo's Top 20

Amedeo Smart

Independent Medical Education

28 September 2015

Multidisciplinary Journal Club

  1. Dheda K, Barry CE 3rd, Maartens G.
    Lancet 2015.

  1. Carey EJ, Ali AH, Lindor KD.
    Primary biliary cirrhosis.
    Lancet 2015.

  2. Bhatt S, Weiss DJ, Cameron E, Bisanzio D, et al.
    The effect of malaria control on Plasmodium falciparum in Africa between 2000 and 2015.
    Nature 2015.

  3. Chang CH, Lin CH, Caffrey JL, Lee YC, et al.
    Risk of Intracranial Hemorrhage From Statin Use in Asians: A Nationwide Cohort Study.
    Circulation 2015;131:2070-8.

  4. Biffi A, Anderson CD, Battey TW, Ayres AM, et al.
    Association Between Blood Pressure Control and Risk of Recurrent Intracerebral Hemorrhage.
    JAMA 2015;314:904-12.

  1. Turner RS, Thomas RG, Craft S, van Dyck CH, et al.
    A randomized, double-blind, placebo-controlled trial of resveratrol for Alzheimer disease.
    Neurology 2015.

  2. Betts RJ , Prabhu N, Ho AW, Lew FC, et al.
    Influenza A Virus Infection Results in a Robust, Antigen-Responsive and Widely Disseminated Foxp3+ Regulatory T Cell Response.
    J Virol 2011.

  3. Palmqvist S, Zetterberg H, Mattsson N, Johansson P, et al.
    Detailed comparison of amyloid PET and CSF biomarkers for identifying early Alzheimer disease.
    Neurology 2015.

  4. Ellis MJ, Llombart-Cussac A, Feltl D, Dewar JA, et al.
    Fulvestrant 500 mg Versus Anastrozole 1 mg for the First-Line Treatment of Advanced Breast Cancer: Overall Survival Analysis From the Phase II FIRST Study.
    J Clin Oncol 2015.

  5. King TA, Pilewskie M, Muhsen S, Patil S, et al.
    Lobular Carcinoma in Situ: A 29-Year Longitudinal Experience Evaluating Clinicopathologic Features and Breast Cancer Risk.
    J Clin Oncol 2015.

  1. Amariglio RE, Mormino EC, Pietras AC, Marshall GA, et al.
    Subjective cognitive concerns, amyloid-beta, and neurodegeneration in clinically normal elderly.
    Neurology 2015;85:56-62.

  2. Sovio U, White IR, Dacey A, Pasupathy D, et al.
    Screening for fetal growth restriction with universal third trimester ultrasonography in nulliparous women in the Pregnancy Outcome Prediction (POP) study: a prospective cohort study.
    Lancet 2015.

  3. Torres J, Boyapati RK, Kennedy N, Louis E, et al.
    Systematic Review of Effects of Withdrawal of Immunomodulators or Biologic Agents From Patients with Inflammatory Bowel Disease.
    Gastroenterology 2015.

  4. Kappos L, Radue EW, Comi G, Montalban X, et al.
    Switching from natalizumab to fingolimod: A randomized, placebo-controlled study in RRMS.
    Neurology 2015;85:29-39.

  5. Petta S, Maida M, Macaluso FS, Barbara M, et al.
    Hepatitis C Virus Infection is Associated With Increased Cardiovascular Mortality: A Meta-analysis of Observational Studies.
    Gastroenterology 2015.

  1. Winters N, Butler-Laporte G, Menzies D.
    Efficacy and safety of World Health Organization group 5 drugs for multidrug-resistant tuberculosis treatment.
    Eur Respir J 2015.

  2. Demoly P, Hagedoorn P, de Boer AH, Frijlink HW, et al.
    The clinical relevance of dry powder inhaler performance for drug delivery.
    Respir Med 2014;108:1195-203.

  3. Chao TF, Liu CJ, Tuan TC, Chen SJ, et al.
    Rate-Control Treatment and Mortality in Atrial Fibrillation.
    Circulation 2015.

  4. Toso C, Meeberg G, Hernandez-Alejandro R, Dufour JF, et al.
    Total Tumor Volume and Alpha Fetoprotein for selection of transplant candidates with hepatocellular carcinoma: A prospective validation.
    Hepatology 2015.

  5. Pigott K, Rick J, Xie SX, Hurtig H, et al.
    Longitudinal study of normal cognition in Parkinson disease.
    Neurology 2015.


Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016